FDA Inspection
Encompass Pharmaceutical Services Inc.Encompass Pharmaceutical Services Inc. – FDA Inspection, Nov 1, 2012
Record Details
This FDA Inspection record concerns Encompass Pharmaceutical Services Inc., with an inspection on November 1, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 1, 2012
- Product Type
- Drugs
View Company Profile
ID · 40b438cb-e718-480a-a331-3663a41085fe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 808883
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Encompass Pharmaceutical Services Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 3, 2022 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 5, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Encompass Pharmaceutical Services Inc.
- FDA Inspection 1171216 - 2022-06-03
- FDA Inspection 904553 - 2014-11-13
- FDA Inspection 593339 - 2009-06-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.